VTRS | ViatrisNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$18.92
+$0.25 (+1.34%)

Viatris (VTRS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $18.92 vs 50 $17.55 / 200 $15.95
Projection
No cross projected
Test
No active test
Last cross
Golden cross 24 Sep 2025 ยท projected 26 bars out ยท tested 2 bars

Weekly as of 30 Oct 16:00 ET

Price
above both $19.04 vs 50 $15.18 / 200 $11.72
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 23 Mar 2026 ยท projected 17 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $18.73 vs 50 $18.11 / 200 $17.06
Projection
No cross projected
Test
No active test
Last cross
Golden cross 9 Jul 2025 ยท projected 25 bars out

Cross history

22
crosses on record since 2022
12 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 23 Mar 2026Golden moderateweekly17 bars outNot tested
24 Sep 2025Golden moderatedaily26 bars out2 bar cross test
9 Jul 2025Golden4-hour25 bars outโ€”
27 Feb 2025Death steepdaily26 bars outNot tested
week of 24 Feb 2025Death flatweeklynot projected1 bar cross test

About VTRS

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$135M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.